Colour theme
Theme
Sign in
Insider · CIK 0001807359

Epperly Melissa B,

CIK 0001807359 Name as filed on the most recent filing

Filed as Epperly Melissa B, (19)

52 transaction lines · from 19 filings · filed 2020-11-25 to 2026-07-01 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-20 05:22 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

52 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-20 05:22 UTC.

Transactions filed by this insider
Direction Date Issuer Code Shares Price Value USD Filing
2026-06-29 Roivant Sciences Ltd.
ROIV
S, Open-market sale 15,002 disposed 34.32 514,868.64 Form 4, filing 0001807359-26-000010
2026-06-29 Roivant Sciences Ltd.
ROIV
S, Open-market sale 2,748 disposed 34.71 95,383.08 Form 4, filing 0001807359-26-000010
2026-03-16 Roivant Sciences Ltd.
ROIV
S, Open-market sale 41,861 disposed 28.68 1,200,573.48 Form 4, filing 0001807359-26-000004
2024-02-12 Zentalis Pharmaceuticals, Inc.
ZNTL
S, Open-market sale 2,573 disposed 11.44 29,435.12 Form 4, filing 0001725160-24-000043
2024-02-02 Zentalis Pharmaceuticals, Inc.
ZNTL
S, Open-market sale 8,669 disposed 11.54 100,040.26 Form 4, filing 0001725160-24-000028
2023-10-04 Zentalis Pharmaceuticals, Inc.
ZNTL
S, Open-market sale 4,594 disposed 19.43 89,245.34 Form 4, filing 0001725160-23-000179
2023-10-04 Zentalis Pharmaceuticals, Inc.
ZNTL
S, Open-market sale 888 disposed 19.91 17,680.26 Form 4, filing 0001725160-23-000179
2023-02-14 Zentalis Pharmaceuticals, Inc.
ZNTL
S, Open-market sale 5,227 disposed 19.98 104,410.89 Form 4, filing 0001725160-23-000035
2023-02-13 Zentalis Pharmaceuticals, Inc.
ZNTL
S, Open-market sale 2,624 disposed 20.42 53,593.63 Form 4, filing 0001725160-23-000035
2022-04-04 Zentalis Pharmaceuticals, Inc.
ZNTL
S, Open-market sale 8,094 disposed 48.75 394,562.26 Form 4, filing 0001725160-22-000069
2022-04-04 Zentalis Pharmaceuticals, Inc.
ZNTL
S, Open-market sale 4,512 disposed 51.99 234,561.73 Form 4, filing 0001725160-22-000069
2022-04-04 Zentalis Pharmaceuticals, Inc.
ZNTL
S, Open-market sale 2,818 disposed 50.70 142,865.56 Form 4, filing 0001725160-22-000069
2022-04-04 Zentalis Pharmaceuticals, Inc.
ZNTL
S, Open-market sale 1,303 disposed 49.90 65,022.05 Form 4, filing 0001725160-22-000069
2022-04-04 Zentalis Pharmaceuticals, Inc.
ZNTL
S, Open-market sale 353 disposed 52.44 18,510.83 Form 4, filing 0001725160-22-000069
2022-02-23 Zentalis Pharmaceuticals, Inc.
ZNTL
S, Open-market sale 1,211 disposed 48.81 59,109.27 Form 4, filing 0001725160-22-000047
2022-02-23 Zentalis Pharmaceuticals, Inc.
ZNTL
S, Open-market sale 702 disposed 49.59 34,811.48 Form 4, filing 0001725160-22-000047
2021-08-19 Zentalis Pharmaceuticals, Inc.
ZNTL
P, Open-market purchase 8,285 acquired 52.00 430,800.12 Form 4, filing 0001725160-21-000185
2021-08-18 Zentalis Pharmaceuticals, Inc.
ZNTL
P, Open-market purchase 1,326 acquired 52.00 68,948.02 Form 4, filing 0001725160-21-000185
2021-07-01 Zentalis Pharmaceuticals, Inc.
ZNTL
S, Open-market sale 1,378 disposed 51.15 70,479.33 Form 4, filing 0001725160-21-000163
2021-07-01 Zentalis Pharmaceuticals, Inc.
ZNTL
S, Open-market sale 805 disposed 52.01 41,864.99 Form 4, filing 0001725160-21-000163
2021-07-01 Zentalis Pharmaceuticals, Inc.
ZNTL
S, Open-market sale 700 disposed 50.10 35,073.01 Form 4, filing 0001725160-21-000163
2021-07-01 Zentalis Pharmaceuticals, Inc.
ZNTL
S, Open-market sale 200 disposed 53.18 10,637.00 Form 4, filing 0001725160-21-000163
2021-06-01 Zentalis Pharmaceuticals, Inc.
ZNTL
S, Open-market sale 2,883 disposed 53.99 155,660.95 Form 4, filing 0001725160-21-000135
2021-06-01 Zentalis Pharmaceuticals, Inc.
ZNTL
S, Open-market sale 200 disposed 54.90 10,980.00 Form 4, filing 0001725160-21-000135
2021-05-03 Zentalis Pharmaceuticals, Inc.
ZNTL
S, Open-market sale 1,122 disposed 60.14 67,479.88 Form 4, filing 0001725160-21-000120
2021-05-03 Zentalis Pharmaceuticals, Inc.
ZNTL
S, Open-market sale 950 disposed 59.83 56,839.16 Form 4, filing 0001725160-21-000120
2021-05-03 Zentalis Pharmaceuticals, Inc.
ZNTL
S, Open-market sale 661 disposed 58.04 38,367.68 Form 4, filing 0001725160-21-000120
2021-05-03 Zentalis Pharmaceuticals, Inc.
ZNTL
S, Open-market sale 350 disposed 56.99 19,948.00 Form 4, filing 0001725160-21-000120
2021-04-05 Zentalis Pharmaceuticals, Inc.
ZNTL
S, Open-market sale 13,792 disposed 43.37 598,099.73 Form 4, filing 0001725160-21-000090
2021-04-05 Zentalis Pharmaceuticals, Inc.
ZNTL
S, Open-market sale 3,083 disposed 43.43 133,895.61 Form 4, filing 0001725160-21-000090
2021-04-05 Zentalis Pharmaceuticals, Inc.
ZNTL
S, Open-market sale 149 disposed 44.21 6,588.01 Form 4, filing 0001725160-21-000090
2021-04-05 Zentalis Pharmaceuticals, Inc.
ZNTL
S, Open-market sale 83 disposed 45.06 3,740.03 Form 4, filing 0001725160-21-000090
2021-03-01 Zentalis Pharmaceuticals, Inc.
ZNTL
S, Open-market sale 3,083 disposed 41.67 128,482.48 Form 4, filing 0001725160-21-000050
2021-02-01 Zentalis Pharmaceuticals, Inc.
ZNTL
S, Open-market sale 2,700 disposed 37.45 101,122.56 Form 4, filing 0001725160-21-000022
2021-02-01 Zentalis Pharmaceuticals, Inc.
ZNTL
S, Open-market sale 383 disposed 38.33 14,682.11 Form 4, filing 0001725160-21-000022
2021-01-04 Zentalis Pharmaceuticals, Inc.
ZNTL
S, Open-market sale 1,583 disposed 52.73 83,477.45 Form 4, filing 0001725160-21-000005
2021-01-04 Zentalis Pharmaceuticals, Inc.
ZNTL
S, Open-market sale 800 disposed 50.36 40,287.04 Form 4, filing 0001725160-21-000005
2021-01-04 Zentalis Pharmaceuticals, Inc.
ZNTL
S, Open-market sale 600 disposed 51.58 30,949.32 Form 4, filing 0001725160-21-000005
2021-01-04 Zentalis Pharmaceuticals, Inc.
ZNTL
S, Open-market sale 100 disposed 53.20 5,320.00 Form 4, filing 0001725160-21-000005
2020-12-07 Zentalis Pharmaceuticals, Inc.
ZNTL
S, Open-market sale 4,983 disposed 53.71 267,642.41 Form 4, filing 0001725160-20-000059
2020-12-07 Zentalis Pharmaceuticals, Inc.
ZNTL
S, Open-market sale 971 disposed 52.53 51,005.95 Form 4, filing 0001725160-20-000059
2020-12-07 Zentalis Pharmaceuticals, Inc.
ZNTL
S, Open-market sale 391 disposed 54.39 21,265.04 Form 4, filing 0001725160-20-000059
2020-12-07 Zentalis Pharmaceuticals, Inc.
ZNTL
S, Open-market sale 119 disposed 50.84 6,049.84 Form 4, filing 0001725160-20-000059
2020-12-04 Zentalis Pharmaceuticals, Inc.
ZNTL
S, Open-market sale 3,877 disposed 51.17 198,396.95 Form 4, filing 0001725160-20-000059
2020-12-04 Zentalis Pharmaceuticals, Inc.
ZNTL
S, Open-market sale 3,343 disposed 50.76 169,699.71 Form 4, filing 0001725160-20-000059
2020-12-02 Zentalis Pharmaceuticals, Inc.
ZNTL
S, Open-market sale 1,525 disposed 51.33 78,273.22 Form 4, filing 0001725160-20-000048
2020-12-02 Zentalis Pharmaceuticals, Inc.
ZNTL
S, Open-market sale 700 disposed 50.34 35,237.02 Form 4, filing 0001725160-20-000048
2020-12-02 Zentalis Pharmaceuticals, Inc.
ZNTL
S, Open-market sale 500 disposed 52.27 26,136.00 Form 4, filing 0001725160-20-000048
2020-12-02 Zentalis Pharmaceuticals, Inc.
ZNTL
S, Open-market sale 358 disposed 53.17 19,034.54 Form 4, filing 0001725160-20-000048
2020-11-23 Zentalis Pharmaceuticals, Inc.
ZNTL
S, Open-market sale 2,783 disposed 46.51 129,436.50 Form 4, filing 0001725160-20-000042

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Codes on this page
S, Open-market sale
Open-market sale
P, Open-market purchase
Open-market purchase

Every value is as reported on the Form 4. A price the filing did not report is marked Not reported and no value is computed from it. Codes outside the open market, drawn in grey behind a dashed rule, are compensation and administrative machinery rather than a decision to trade at the prevailing price.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 3
  • Open-market sale 49
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. Epperly Melissa B,, insider transactions. Retrieved 2026-08-21 from https://ebomi.com/insider/0001807359

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.